Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer-Reference-Cited by-同舟云学术

Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer

Published:2019-10-15 Issue:1 Volume:20 Page:136-158
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

López-Cortés Andrés^ORCID,Paz-y-Miño César^ORCID,Guerrero Santiago^ORCID,Jaramillo-Koupermann Gabriela^ORCID,León Cáceres Ángela,Intriago-Baldeón Dámaris P.^ORCID,García-Cárdenas Jennyfer M.^ORCID,Guevara-Ramírez Patricia^ORCID,Armendáriz-Castillo Isaac^ORCID,Leone Paola E.^ORCID,Quiñones Luis Abel,Cayún Juan Pablo,Soria Néstor W.

Funder

CYTED Ciencia y Tecnología para el Desarrollo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-019-0102-4.pdf

Reference167 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Puccini A, Lenz H-J. Colorectal cancer in 2017: practice-changing updates in the adjuvant and metastatic setting. Nat Rev Clin Oncol. 2017;15:2–3.

3. Sabarinathan R, Pich O, Martincorena I, Rubio-Perez C, Juul M, Wala J, et al. The whole-genome panorama of cancer drivers. 2017. https://www.biorxiv.org/content/10.1101/190330v1 .